Drugs linked to dementia, falls and death in autistic adults
Exposure to medicines with anticholinergic effects was 80.0% in adults with autism alone, versus 61.3% in controls without autism or intellectual disability.
Our read
Populations- Studied:
- Preprint: cohort study of adults with or without autism or intellectual disability
- What changed:
- Dementia, falls, and death were more common with stronger anticholinergic medication effects
- The catch:
- Conditions prompting prescriptions could contribute to the links with dementia, falls, and death
- In the record:
- The 15th paper on anticholinergic medications with results in people; 19 on record in all.
- Why it’s aging research:
- It measures an outcome that worsens with age.
Editor of record: Boris Djordjevic · AgingResearch.News
US adults aged 40 and older with autism, intellectual disability, both or neither were compared in a retrospective cohort study of linked Medicare and Medicaid claims from 2017–2019. Researchers examined medicines with anticholinergic effects, which block the action of a chemical messenger used by nerves.
Exposure reached 92.5% in adults with both autism and intellectual disability and 88.6% in those with intellectual disability alone. It reached 80.0% in those with autism alone, compared with 61.3% in controls. Exposure was linked to Alzheimer’s disease and related dementias, falls and death. Associations increased stepwise with the strength of anticholinergic effects and were more prominent in adults with autism or intellectual disability than in controls.
Why it matters
Contributors to aging-related health risks in autistic adults remain underexplored. The authors identified anticholinergic medication exposure as a potential modifiable risk factor.
Caveats
The claims-based comparisons could not rule out whether the conditions prompting prescriptions contributed to the links. The findings concern Medicare and Medicaid beneficiaries aged 40 and older, and the preprint has not been peer-reviewed.
- Anticholinergic medications
- Falls
- Autism
- Intellectual disability
- Alzheimer's disease and related dementias
- Humans
The paper
Anticholinergic Medications and Health in Adults with Autism or Intellectual Disability
George Mason University; The George Washington University
medRxiv, Nov 5, 2026, Open access, CC BY-NC-ND, Preprint, not yet peer-reviewed
Comments
Be the first to comment.